N''-{amino[(3-fluorobenzyl)imino]methyl}guanidine

ID: ALA4069147

Chembl Id: CHEMBL4069147

PubChem CID: 83032501

Max Phase: Preclinical

Molecular Formula: C9H12FN5

Molecular Weight: 209.23

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(N)=N/C(N)=N/Cc1cccc(F)c1

Standard InChI:  InChI=1S/C9H12FN5/c10-7-3-1-2-6(4-7)5-14-9(13)15-8(11)12/h1-4H,5H2,(H6,11,12,13,14,15)

Standard InChI Key:  HQKFWCBMCSEECU-UHFFFAOYSA-N

Associated Targets(Human)

TAAR1 Tclin Trace amine-associated receptor 1 (1397 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Taar1 Trace amine-associated receptor 1 (1619 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Taar5 Trace amine-associated receptor 5 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 209.23Molecular Weight (Monoisotopic): 209.1077AlogP: -0.09#Rotatable Bonds: 2
Polar Surface Area: 102.78Molecular Species: BASEHBA: 1HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 11.16CX LogP: 0.19CX LogD: -3.20
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.47Np Likeness Score: -0.92

References

1. Tonelli M, Espinoza S, Gainetdinov RR, Cichero E..  (2017)  Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies.,  127  [PMID:27823885] [10.1016/j.ejmech.2016.10.058]

Source